cobalt has been researched along with rofecoxib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chavez, JC; LaManna, JC; Pichiule, P | 1 |
1 other study(ies) available for cobalt and rofecoxib
Article | Year |
---|---|
Hypoxic regulation of angiopoietin-2 expression in endothelial cells.
Topics: Angiopoietin-2; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cells, Cultured; Cobalt; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Deferoxamine; Dinoprostone; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitory Concentration 50; Iron Chelating Agents; Isoenzymes; Lactones; Membrane Proteins; Nuclear Proteins; Oligonucleotides, Antisense; Oxygen; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Recombinant Proteins; RNA, Messenger; Sulfones; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |